Last reviewed · How we verify
NCT06077123: DETECT
Telemonitoring Platforms and Chemotherapy-Associated Toxicity
NA trial testing Contigo Application in Cancer in 80 participants. Currently enrolling.
30 December 2024
Quick facts
| Lead sponsor | Universidad Nacional Andres Bello |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 April 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 March 2025 |
| Sites | 2 locations across Chile |
Drugs / interventions tested
- Contigo Application
Conditions studied
- Cancer — all drugs for Cancer →
- Chemotherapeutic Agent Toxicity — all drugs for Chemotherapeutic Agent Toxicity →
Sponsor
Universidad Nacional Andres Bello
Who can join
18 and older, any sex, with Cancer or Chemotherapeutic Agent Toxicity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this trial is to evaluate the impact of a telemonitoring platform on patient satisfaction with care amongst adult cancer patients receiving chemotherapy. The key questions it seeks to address revolve around the potential improvements in both quality of life and satisfaction with healthcare. Participants in the trial will be provided with a specialized application developed by a team of experienced oncology professionals. Their quality of life and healthcare experience will be compared with that of the control group, who will only receive the standard in-person check-ups established by their healthcare team.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Differential Effects of a Telemonitoring Platform in the Development of Chemotherapy-Associated Toxicity: A Randomized Trial Protocol.
Martínez F, Taramasco C, Espinoza M, Acevedo J, et al · · 2024 · cited 1× · PMID 38535039 · DOI 10.3390/diagnostics14060619
Verify or expand the search:
- PubMed search for NCT06077123
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Universidad Nacional Andres Bello trials
Trials by the same sponsor.
- NCT06727500 — Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric · NA · recruiting
- NCT06725901 — Pediatric Neurogenetic Diagnosis Support Platform · NA · recruiting
- NCT06428032 — Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy · NA · recruiting
- NCT06895850 — Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors · NA · completed
- NCT04489446 — Sildenafil in COVID-19 · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06077123 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional Andres Bello
- Last refreshed: 8 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06077123.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing